Employees and leaders across the pharmaceutical industry are dealing with a heightened state of uncertainty and anxiety. Recent events are not helping. Politics are getting more polarized, financial markets are buckling under the weight of unpredictability, and the labor market is being shaken by everything from AI to new return-to-office policies. Pharmaceutical companies are setting up war rooms to navigate rapid fire regulatory changes and pricing pressures. Uncertainty is not uncommon, but this moment feels different.
Adding to the present urgency is the potential impact of anxiety on mental health and productivity. The United Nations Development Programme’s most recent Human Development Report noted that the number of people expressing stress, sadness, anxiety, anger, or worry is at